Orphazyme: Preparation in progress for filing in 2020

Research Note

2019-06-07

11:28

Orphazyme today announced, based on feedback from the European Medical Agency (EMA), that they are preparing for filing with arimoclomol in Niemann-Pick Disease Type C (NPC). We acknowledge this press release as confirmatory to our timeline.

AH

Anders Hedlund

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.